Therapex | Valuation, Funding Rounds & Stock Price | Caplight
Therapex
Company Overview
Therapex is a biotechnology company that develops small molecule-based anti-cancer drugs and precision medicines for patients with drug-resistant tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
targeted oncology, drug discovery, tyrosine kinase inhibitor, TKI, targeted protein degradation, PROTAC, non-small cell lung cancer, NSCLC, biotech, molecular modeling, in-silico drug design, degrader antibody conjugate, DAC, blood-brain barrier, drug resistance, biopharma, precision medicine, technology licensing
Therapex Comparables
Compare Therapex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| J INTS BIO | 94% | Unlock |
| Black Diamond Therapeutics | 78% | Unlock |
| ArriVent | 76% | Unlock |
| Comparable company | 50% | Unlock |
Therapex Funding Rounds
Historical fundraising activity.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026: Monthly visitors increased 84% MoM, reaching 1.6K.
- Jan 20, 2026: Monthly visitors increased 201% MoM, reaching 4.1K.
Firmographic Details
Headquarters
Seoul
Employee Range
4
Year Founded
2020
Last Funding
—
Frequently Asked Questions
- Is Therapex a public or private company?
- What is the current stock price of Therapex?
- How much is Therapex worth (valuation)?
- Can I buy Therapex stock?
- When was Therapex's last funding round?
- Who are the main investors in Therapex?
- Will Therapex IPO soon?
- How can I track Therapex secondary market activity?